Their approach promises a permanent cure and potential for protection against HIV
The HIV-1 virus has proved to be tenacious, inserting its genome permanently into its victims’ DNA, forcing patients to take a lifelong drug regimen to control the virus and prevent a fresh attack. Now, a team of Temple University School of Medicine researchers has designed a way to snip out the integrated HIV-1 genes for good.
“This is one important step on the path toward a permanent cure for AIDS,” says Kamel Khalili, PhD, Professor and Chair of the Department of Neuroscience at Temple. Khalili and his colleague, Wenhui Hu, MD, PhD, Associate Professor of Neuroscience at Temple, led the work which marks the first successful attempt to eliminate latent HIV-1 virus from human cells. “It’s an exciting discovery, but it’s not yet ready to go into the clinic. It’s a proof of concept that we’re moving in the right direction,” added Dr. Khalili, who is also Director of the Center for Neurovirology and Director of the Comprehensive NeuroAIDS Center at Temple.
In a study published July 21 by the Proceedings of the National Academy of Sciences, Khalili and colleagues detail how they created molecular tools to delete the HIV-1 proviral DNA. When deployed, a combination of a DNA-snipping enzyme called a nuclease and a targeting strand of RNA called a guide RNA (gRNA) hunt down the viral genome and excise the HIV-1 DNA. From there, the cell’s gene repair machinery takes over, soldering the loose ends of the genome back together – resulting in virus-free cells.
“Since HIV-1 is never cleared by the immune system, removal of the virus is required in order to cure the disease,” says Khalili, whose research focuses on the neuropathogenesis of viral infections. The same technique could theoretically be used against a variety of viruses, he says.
The research shows that these molecular tools also hold promise as a therapeutic vaccine; cells armed with the nuclease-RNA combination proved impervious to HIV infection.
Worldwide, more than 33 million people have HIV, including more than 1 million in the United States. Every year, another 50,000 Americans contract the virus, according to the U.S. Centers for Disease Control and Prevention.
The Latest on: HIV
via Google News
The Latest on: HIV
- What 141 HIV/AIDS Patient Groups Thought of 9 Pharma Companies in 2019 | Survey Findings Report 2020 - ResearchAndMarkets.comon August 12, 2020 at 9:13 am
The Patient Perspective - HIV/AIDS Edition - The Views of 141 HIV/AIDS Groups" report has been added to ResearchAndMarkets.com's offering.
- This Playwright Is Helping People Living With HIV to ‘Write It Out!’on August 12, 2020 at 6:24 am
Love told TheBody that people living with HIV of all ages, from all over the world, are encouraged to apply, whether this is their first time writing, or their 500th. “We are excited for writers of ...
- HIV: Updated COVID-19 Resources for Individuals and Physicianson August 12, 2020 at 1:49 am
British HIV Association & Terrence Higgins Trust: COVID-19 risk for PLHIV was updated on 7 August. This statement reviews the available evidence on COVID-19 risk for PLHIV. It notes that some studies ...
- AUM LifeTech awarded NIH grant to develop HIV therapy using RNA targeting technology, commits additional resources to COVID-19 researchon August 11, 2020 at 7:23 am
AUM LifeTech, Inc., a Philadelphia based preclinical stage biotechnology company, has received a Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious ...
- The Program That Keeps Half a Million People With HIV Alive and Well Turns 30 This Monthon August 11, 2020 at 7:10 am
We spoke to two experts about the origin, evolution, and future of the Ryan White CARE Act, passed on August 18, 1990.
- 3-monthly HIV screening is best for young MSMon August 11, 2020 at 4:36 am
Twenty per cent of new HIV infections in the USA arise in young men (aged 13–24 years) who have sex with men (YMSM); however, >50% of YMSM with HIV do not know their HIV status. Mathematical ...
- OPINION: Why SisterLove pushes for more women in HIV clinical trialson August 11, 2020 at 4:33 am
A month after leaving the Atlanta Feminist Women’s Health Center in 1989, Dázon Dixon Diallo founded SisterLove Inc., the oldest women-centered HIV and sexual and reproductive justice advocacy ...
- South Africa's poor scramble for anti-HIV drugs amid viruson August 11, 2020 at 12:27 am
Across Africa and around the world, the COVID-19 pandemic has disrupted the supply of antiretroviral drugs to many of the more than 24 million people who take them, endangering their lives ...
- South Africa’s poor scramble for anti-HIV drugs amid virus | Raleigh News & Observeron August 10, 2020 at 11:26 pm
Across Africa and around the world, the COVID-19 pandemic has disrupted the supply of antiretroviral drugs to many of the more than 24 million people who take them, endangering their lives.
- Research suggests greater access to specific HIV and tuberculosis medications is neededon August 10, 2020 at 6:09 am
A specific combination of HIV and TB treatments, difficult to obtain in certain parts of the world, decreased mortality risk for patients with HIV and multidrug-resistant TB.
via Bing News